Deutsch Intern
  • Riboyzyme_Structure_Revealed_Hoebartner_Okuda
The Okuda Group

Dr. Takumi Okuda

Okuda-Group: Nucleic Acid Chemistry

Dr. Takumi Okuda

Universität Würzburg
Institut für Organische Chemie and 
Center for Nanosystems Chemistry

Am Hubland
97074 Würzburg

Phone: +49 931 31-87541
takumi.okuda@uni-wuerzburg.de

 

CV

Takumi studied pharmaceutical chemistry at Osaka University, Japan, where he developed his interest in nucleic acid chemistry. During his master's studies, he specialized in the synthesis of artificial nucleic acids, receiving his MSc from the Graduate School of Pharmaceutical Sciences in 2017. Continuing at the same institution, he pursued his doctoral research on designing chemically modified nucleic acids for therapeutic applications and obtained his PhD in 2020.
In June 2020, he joined the Höbartner lab as a postdoctoral researcher, where he became fascinated by catalytic RNAs. Currently, his research focuses on developing novel ribozymes essential for RNA modifications in the prebiotic world. Outside the lab, he enjoys staying active at the bouldering gym.
Since July 2025 Takumi has been a junior group leader in Nucleic Acid Chemistry initiating his independet research career.

Current Position

Since 2025 Junior group leader, Institute of Organic Chemistry & Center for Nanosystems Chemistry (CNC), Julius-Maximilians-Universität Würzburg, Germany

Education and Previous Positions

2020–2025 Post-doctoral fellow, Institute of Organic Chemistry, Julius-Maximilians-Universität Würzburg, Germany

2017–2020 Ph.D. in Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, Osaka University, Japan, Advisor: Prof. Satoshi Obika

Open Positions

I am currently looking for motivated students who would like to join my group for a bachelor's, master's, doctoral or postdoctoral thesis. I look forward to answering your questions and receiving your application.
Dr. Takumi Okuda